Interferon-α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-05-089086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Are Indoleamine-2,3-Dioxygenase Producing Human Dendritic Cells a Tool for Suppression of Allogeneic T-cell Responses?

  2007cited by this paper
• Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand

  2007cited by this paper
• Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus

  2007cited by this paper
• Stat3 Mediates Interelukin-6 Inhibition of Human Endothelial Nitric-oxide Synthase Expression*

  2006cited by this paper
• Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo

  2006cited by this paper
• Stat3 mediates interleukin-6 [correction of interelukin-6] inhibition of human endothelial nitric-oxide synthase expression.

  2006cited by this paper
• Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus1

  2006cited by this paper
• Cytokines and vascular permeability

  2006cited by this paper
• Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

  2006cited by this paper
• Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-&agr;

  2006cited by this paper
• Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.

  2006cited by this paper
• Treatments of AIDS-related Kaposi's sarcoma.

  2005cited by this paper
• Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

  2005cited by this paper
• Role of monocytes and macrophages in angiogenesis.

  2005cited by this paper
• Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways

  2005cited by this paper
• Circulating endothelial progenitor cells and cardiovascular outcomes.

  2005cited by this paper
• Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

  2005cited by this paper
• Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis

  2005cited by this paper
• Interferon-α in systemic lupus erythematosus

  2004cited by this paper
• Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.

  2004cited by this paper
• Alpha-interferon and its effects on signalling pathways within cells.

  2004cited by this paper
• Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure

  2004cited by this paper
• IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.

  2004cited by this paper
• Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.

  2004cited by this paper
• Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.

  2004cited by this paper
• Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus

  2004cited by this paper
• IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences.

  2003cited by this paper
• Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

  2003cited by this paper
• Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood

  2003cited by this paper
• Relevance of Monocytic Features for Neovascularization Capacity of Circulating Endothelial Progenitor Cells

  2003cited by this paper
• Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

  2003cited by this paper
• IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.

  2003cited by this paper
• SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.

  2003cited by this paper
• Vascular progenitors: from biology to treatment.

  2002cited by this paper
• The Apoptotic Ligands TRAIL, TWEAK, and Fas Ligand Mediate Monocyte Death Induced by Autologous Lupus T Cells1

  2002cited by this paper
• Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures

  2002cited by this paper
• Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

  2001cited by this paper
• Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus

  2001cited by this paper
• Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

  2001cited by this paper
• Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction

  2001cited by this paper
• Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus

  2001cited by this paper
• Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis.

  2001cited by this paper
• Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach.

  2000cited by this paper
• Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

  2000cited by this paper
• Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.

  1999cited by this paper
• Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells.

  1999cited by this paper
• Interferon-α Primes Macrophages for Lipopolysaccharide-Induced Apoptosis

  1995cited by this paper
• Interferon-alpha primes macrophages for lipopolysaccharide-induced apoptosis.

  1995cited by this paper
• Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism.

  1994cited by this paper
• Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon.

  1992cited by this paper
• Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy

  1992cited by this paper
• Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

  1992cited by this paper
• Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.

  1983cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper

• Genetic variants in HSP40 co-chaperones modulate ischemic heart disease risk

  2025cites this paper
• Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients

  2025cites this paper
• Cardiovascular Events in Lupus Nephritis: A Systematic Review and Meta-Analysis

  2025cites this paper
• Immune dysregulation and lipid interactions in systemic lupus erythematosus-associated atherosclerosis: mechanisms and pathogenesis

  2025cites this paper
• Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics

  2024cites this paper
• The vascular endothelial growth factor as a candidate biomarker of systemic lupus erythematosus: a GRADE-assessed systematic review and meta-analysis

  2024cites this paper
• Vascular damage in systemic lupus erythematosus

  2024cites this paper
• Platelet extracellular vesicles preserve lymphatic endothelial cell integrity and enhance lymphatic vessel function

  2024cites this paper
• Autoimmune diseases and atherosclerotic cardiovascular disease

  2024cites this paper
• Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus

  2024cites this paper
• Novel insights into molecular signatures and pathogenic cell populations shared by systemic lupus erythematosus and vascular dementia

  2023cites this paper
• Breaking down the cellular responses to type I interferon neurotoxicity in the brain

  2023cites this paper
• Nailfold capillaroscopy in Egyptian systemic lupus erythematosus (SLE) patients: correlation with demographic features and serum levels of IL 17A and IFNs I

  2023cites this paper
• An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation

  2023cites this paper
• Type I Interferons induce endothelial destabilization in Systemic Lupus Erythematosus in a Tie2-dependent manner

  2023cites this paper
• Identification of cell types, states and programs by learning gene set representations

  2023cites this paper
• Proteomic analysis of lysine 2-hydroxyisobutyryl in SLE reveals protein modification alteration in complement and coagulation cascades and platelet activation Pathways

  2023cites this paper
• Endothelial Progenitor Cells in Autoimmune Disorders

  2023cites this paper
• Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus

  2023cites this paper
• Anti-melanoma Differentiation-associated Gene 5 Antibody-positive Dermatomyositis Presenting as Refractory Gingivitis at the First Clinical Manifestation

  2023cites this paper
• Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers

  2022cites this paper
• Systemic Lupus Erythematosus and Cardiovascular Disease

  2022cites this paper
• Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus

  2022cites this paper
• Serum Cytokines Predict the Severity of Coronary Artery Disease Without Acute Myocardial Infarction

  2022cites this paper
• Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin

  2022cites this paper
• Endothelial function and endothelial progenitor cells in systemic lupus erythematosus

  2022cites this paper
• CD8+ T-Cells in Juvenile-Onset SLE: From Pathogenesis to Comorbidities

  2022cites this paper
• Coronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain

  2022cites this paper
• Interferons and systemic lupus erythematosus: Pathogenesis, clinical features and treatments in interferon-driven disease.

  2022cites this paper
• Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases

  2022cites this paper
• Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.

  2022cites this paper
• Type I Interferons and the Perpetuation of a Loss of Tolerance

  2021cites this paper
• Pathophysiology of Antiphospholipid Syndrome

  2021cites this paper
• Tissue injury—the biology

  2021cites this paper
• The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases

  2021cites this paper
• Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE

  2021cites this paper
• Thrombosis and Haemostasis Pathophysiology of the Antiphospholipid Antibody Syndrome

  2021cites this paper
• RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells

  2021cites this paper
• Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients

  2021cites this paper
• Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma

  2021cites this paper
• The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis

  2021cites this paper
• Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation

  2021cites this paper
• Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets

  2021cites this paper
• Bite of the wolf: innate immune responses propagate autoimmunity in lupus.

  2021cites this paper
• Mechanisms of vascular damage in systemic lupus erythematosus

  2021cites this paper
• NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases

  2021cites this paper
• Polymorphonuclear cells

  2021cites this paper
• Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erytheematosus: A systematic review.

  2021cites this paper
• Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders

  2020cites this paper
• Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca2+ signaling: A novel approach for an old disease.

  2020cites this paper
• Ruptured hemorrhagic corpus luteum as a presenting symptom of systemic lupus erythematous

  2020cites this paper
• Granulocytes: Neutrophils, Basophils, Eosinophils

  2020cites this paper
• Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies.

  2020cites this paper
• CD34+ CD133+ CD309+ circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients - a case-control study and meta-regression analysis.

  2020cites this paper
• IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus

  2020cites this paper
• Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus

  2020cites this paper
• Proteomic, biomechanical and functional analyses define neutrophil heterogeneity in systemic lupus erythematosus

  2020cites this paper
• Cardiovascular Disease in Systemic Lupus Erythematosus: recent data on epidemiology, risk factors and prevention.

  2019cites this paper
• Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse

  2019cites this paper
• Pathogenesis of Accelerated Atherosclerosis and Vascular Injury in Systemic Lupus Erythematosus

  2019cites this paper
• Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus

  2019cites this paper
• Endothelium structure and function in kidney health and disease

  2019cites this paper
• Type-I interferons in atherosclerosis

  2019influential citation
• Interferon pathway in SLE: one key to unlocking the mystery of the disease

  2019cites this paper
• Rheumatoid arthritis (RA) and cardiovascular disease.

  2019cites this paper
• B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus

  2019influential citation
• Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus

  2019cites this paper
• L-sepiapterin restores SLE serum-induced markers of endothelial function in endothelial cells

  2019cites this paper
• Cardiovascular risk in women with autoimmune rheumatic diseases

  2019cites this paper
• Systemic lupus erythematosus and endothelial dysfunction: a close relationship.

  2019cites this paper
• Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients

  2019cites this paper
• Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/Rab4 expression and mTOR activation.

  2019cites this paper
• Update on the pathogenesis of central nervous system lupus.

  2019cites this paper
• Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus

  2018cites this paper
• Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

  2018cites this paper
• Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases

  2018cites this paper
• Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy.

  2018cites this paper
• Anti-Vasculogenic Effect of Mycophenolic Acid

  2018cites this paper
• Accelerated model of lupus autoimmunity and vasculopathy driven by toll-like receptor 7/9 imbalance

  2018cites this paper
• Mycophenolic acid induces senescence of vascular precursor cells

  2018cites this paper
• EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

  2018cites this paper
• The non-haemostatic role of platelets in systemic lupus erythematosus

  2018cites this paper
• Endothelial progenitor cells and vascular endothelial growth factor in patients with Takayasu’s arteritis

  2018cites this paper
• The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients.

  2018cites this paper
• Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand.

  2018cites this paper
• Plasma levels of β2-microglobulin are associated with atherosclerosis in patients with systemic lupus erythematosus: a cross-sectional cohort study

  2018cites this paper
• Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk

  2018influential citation
• Under crossfire: thromboembolic risk in systemic lupus erythematosus.

  2018cites this paper
• The Role of Toll-Like Receptors in Autoimmune Diseases through Failure of the Self-Recognition Mechanism

  2017influential citation
• Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation

  2017cites this paper
• Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.

  2017cites this paper
• Neutrophils in Homeostasis, Immunity, and Cancer.

  2017cites this paper
• USP7 is associated with greater disease activity in systemic lupus erythematosus via stabilization of the IFNα receptor.

  2017cites this paper
• Visfatin induces the apoptosis of endothelial progenitor cells via the induction of pro-inflammatory mediators through the NF-κB pathway

  2017cites this paper
• Decidual T Cells Exhibit a Highly Differentiated Phenotype and Demonstrate Potential Fetal Specificity and a Strong Transcriptional Response to IFN

  2017cites this paper
• JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

  2017cites this paper
• Targeting interferons as a strategy for systemic sclerosis treatment.

  2017cites this paper
• IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus

  2017cites this paper
• Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus

  2017cites this paper
• Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction

  2017cites this paper